Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$5.98 - $9.31 $1.04 Million - $1.62 Million
-174,200 Reduced 57.02%
131,300 $814,000
Q1 2024

May 07, 2024

BUY
$6.7 - $12.0 $10,050 - $18,000
1,500 Added 0.49%
305,500 $2.88 Million
Q4 2023

Feb 14, 2024

SELL
$3.18 - $6.86 $1,272 - $2,744
-400 Reduced 0.13%
304,000 $2.05 Million
Q3 2023

Nov 14, 2023

BUY
$3.25 - $6.08 $59,800 - $111,872
18,400 Added 6.43%
304,400 $1.35 Million
Q2 2023

Aug 11, 2023

SELL
$2.26 - $3.8 $27,119 - $45,600
-12,000 Reduced 4.03%
286,000 $943,000
Q1 2023

May 16, 2023

BUY
$2.83 - $13.99 $154,518 - $763,854
54,600 Added 22.43%
298,000 $849,000
Q4 2022

Feb 14, 2023

SELL
$5.01 - $8.35 $168,837 - $281,395
-33,700 Reduced 12.16%
243,400 $1.77 Million
Q3 2022

Nov 14, 2022

BUY
$4.92 - $9.1 $350,304 - $647,920
71,200 Added 34.58%
277,100 $2.24 Million
Q2 2022

Aug 15, 2022

BUY
$4.2 - $24.0 $488,040 - $2.79 Million
116,200 Added 129.54%
205,900 $1.01 Million
Q1 2022

May 16, 2022

BUY
$9.96 - $23.65 $432,264 - $1.03 Million
43,400 Added 93.74%
89,700 $2.12 Million
Q4 2021

Feb 14, 2022

SELL
$14.0 - $28.44 $131,600 - $267,336
-9,400 Reduced 16.88%
46,300 $819,000
Q3 2021

Nov 15, 2021

BUY
$7.28 - $30.97 $405,496 - $1.73 Million
55,700 New
55,700 $1.57 Million

Others Institutions Holding FULC

About Fulcrum Therapeutics, Inc.


  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $187M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.